The NASDAQ OMX Group, Inc. (NASDAQ:NDAQ) announced today the result of the semi-annual review of the OMX Copenhagen 20 Index (NASDAQ OMX Copenhagen: OMXC20), which will become effective with the market open on Monday, June 21, 2010.
As a result of the re-ranking NASDAQ OMX will add Coloplast to the OMXC20 Index and remove Genmab.
The OMXC20 Index is the NASDAQ OMX Copenhagen's tradable index. It was introduced July 3, 1989 as an underlying instrument for futures and options. The OMXC20 Index has a base value of 100 and is weighted in terms of free floated market value.
The OMX Copenhagen 20 Index constituents effective June 21, 2010 are:
A.P. Møller - Mærsk A
A.P. Møller - Mærsk B
Carlsberg A/S B
Coloplast B
D/S Norden
Danisco
Danske Bank
DSV
FLSmidth & Co.
Jyske Bank A/S
Lundbeck
NKT Holding
Nordea Bank AB
Novo Nordisk B
Novozymes B
Sydbank
Topdanmark
TrygVesta
Vestas Wind Systems
William Demant Holding